This inventor holds 1 USPTO granted patent. Top assignee: Shenyang Pharmaceutical University. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014
Title: Shihui Wang: Innovator in Estrogen Receptor Modulation
Introduction
Shihui Wang is a notable inventor based in Shenyang, China. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of compounds that modulate estrogen receptors. His work is essential for advancing therapeutic options in various medical conditions.
Latest Patents
Wang holds a patent for "Furo[3,2-g]chromene compounds and uses thereof." This patent discloses furo[3,2-g]chromene derivatives represented by a specific formula, including stereoisomers, pharmaceutically acceptable salts, and pharmaceutical compositions. These compounds are recognized for their potential uses as estrogen receptor modulators, which can have significant implications in medical treatments.
Career Highlights
Shihui Wang is affiliated with Shenyang Pharmaceutical University, where he contributes to research and education in pharmaceutical sciences. His expertise in the development of innovative compounds has positioned him as a valuable asset in the academic and research community.
Collaborations
Wang has collaborated with notable colleagues, including Chun Hu and Yan Wang. These partnerships enhance the research output and foster innovation in their respective fields.
Conclusion
Shihui Wang's contributions to the field of estrogen receptor modulation through his patented compounds highlight his role as an influential inventor. His work at Shenyang Pharmaceutical University continues to pave the way for advancements in pharmaceutical research and development.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile